XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.62+0.08 (+5.19%)
Close on Nov 17, 2026Market cap $15.33MP/E –Yield –
XTL Biopharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2024 it was 0.7%.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0.7% | – |
See a number that looks wrong?